Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition. [electronic resource]
- Radiation research Apr 2011
- 444-51 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
1938-5404
10.1667/RR2317.1 doi
Androgens--therapeutic use Aurora Kinase B Aurora Kinases Cell Line, Tumor Dose-Response Relationship, Drug Humans Male Organophosphates--administration & dosage Prostatic Neoplasms--drug therapy Protein Serine-Threonine Kinases--antagonists & inhibitors Quinazolines--administration & dosage Radiation Tolerance--drug effects Treatment Failure Treatment Outcome